Hematology NewsNovel bispecific CAR shows promise in B-cell malignanciesJanuary 25, 2019Aggressive LymphomasCellular TherapyLymphoma & Plasma Cell DisordersTransplantationImmuno-oncologyImmunotherapyB Cell Lymphoma
Hematology NewsUninterrupted ibrutinib with CAR T could improve CLL outcomesJanuary 25, 2019CLLLeukemia, Myelodysplasia, TransplantationImmunotherapyImmuno-oncologyCellular Therapy
Hematology NewsArmored CAR protects T cells, induces remissionsJanuary 4, 2019Cellular TherapyImmuno-oncologyLymphoma & Plasma Cell DisordersCLLAggressive LymphomasImmunotherapyB Cell Lymphoma
Hematology NewsLong-term side effects of CAR T cells mostly mildJanuary 4, 2019Cellular TherapyCLLAggressive LymphomasImmunotherapyB Cell Lymphoma
Oncology PracticeAge-related gene expression may affect responses to RCC therapyDecember 4, 2018Renal Cell CarcinomaImmunotherapyGenitourinary CancerImmuno-oncology
The Journal of Community and Supportive OncologyImmunotherapy may hold the key to defeating virally associated cancersNovember 25, 2018Head & Neck/Thyroid CancersGenitourinary CancerGynecologic CancerGastroenterologyImmunotherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsASH preview: Studies target CAR T-cell improvementsNovember 21, 2018Cellular TherapyImmunotherapyB Cell Lymphoma
Hematology NewsNICE looks likely to reject use of Kymriah for DLBCLSeptember 24, 2018Cellular TherapyBusiness of MedicineImmunotherapyPractice ManagementAggressive LymphomasB Cell Lymphoma
Hematology NewsKymriah cost effectiveness depends on long-term outcomesSeptember 17, 2018ALLBusiness of MedicineCellular TherapyPractice ManagementImmunotherapyImmuno-oncologyB Cell Lymphoma
Hematology NewsEarly CAR T data on P-BCMA-101 in refractory myelomaSeptember 17, 2018Multiple MyelomaCellular TherapyImmunotherapy
Hematology NewsNovartis nabs first CAR T approval in CanadaSeptember 7, 2018ALLAggressive LymphomasImmunotherapyFollicular LymphomaB Cell Lymphoma
Hematology NewsEngland green-lights coverage of one CAR T-cell therapySeptember 6, 2018Business of MedicinePractice ManagementImmunotherapyALLCellular TherapyAggressive LymphomasB Cell Lymphoma
Hematology NewsEuropean Commission approves first CAR T-cell therapiesAugust 28, 2018ALLPediatricsLeukemia, Myelodysplasia, TransplantationAggressive LymphomasImmunotherapyB Cell Lymphoma
The Journal of Community and Supportive OncologyImmunotherapy-related adverse effects: how to identify and treat them in the emergency departmentAugust 26, 2018ImmunotherapyPatient & Survivor Care
The Journal of Community and Supportive OncologyMeeting the potential of immunotherapy: new targets provide rational combinationsAugust 15, 2018GastroenterologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersImmunotherapyLymphoma & Plasma Cell DisordersMelanoma
